Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Benzonatate
Drug ID BADD_D00240
Description Benzonatate is an oral antitussive drug used in the relief and suppression of cough in patients older than ten years of age.[A5790] Currently, benzonatate is the only non-narcotic antitussive available as a prescription drug.[A189519] It works to reduce the activity of cough reflex by desensitizing the tissues of the lungs and pleura involved in the cough reflex. Benzonatate was approved by the FDA in 1958 under the market name Tessalon Perles.[A5790] Because its chemical structure resembles that of the anesthetic agents in the para-amino-benzoic acid class (such as [procaine] and [tetracaine]), benzonatate exhibits anesthetic or numbing action.[L11193] Although it not prone to drug misuse or abuse, benzonatate is associated with a risk for severe toxicity and overdose, especially in children.[A189513]
Indications and Usage Benzonatate is indicated for the symptomatic relief of cough.[L11193]
Marketing Status approved
ATC Code R05DB01
DrugBank ID DB00868
KEGG ID D00242
MeSH ID C029755
PubChem ID 7699
TTD Drug ID D0Q2ES
NDC Product Code 72789-014; 72789-232; 82982-023; 10888-8126; 51655-754; 55154-3372; 61919-573; 61919-638; 63187-928; 64380-713; 67296-1549; 67296-1768; 68382-091; 68788-8133; 71335-1329; 71335-1553; 72789-230; 72789-231; 72865-118; 11788-027; 11788-028; 42806-715; 53002-0413; 53002-5891; 63629-2474; 65162-536; 70934-884; 70934-893; 71205-037; 71205-887; 71335-1544; 72789-025; 17381-295; 0904-7153; 11788-029; 51655-776; 53002-0412; 55154-7995; 55700-923; 62332-427; 63629-2444; 65162-537; 67296-1454; 70934-675; 61919-517; 62135-440; 63187-606; 63187-799; 63629-1229; 65841-614; 68084-214; 71205-067; 71205-643; 71205-971; 82982-064; 10888-8125; 65655-0010; 31722-957; 42708-171; 50090-4969; 50090-6080; 50090-6205; 55700-922; 63187-076; 63739-029; 67296-1475; 68071-2624; 68788-7560; 68788-8405; 69452-144; 71205-659; 71205-662; 71205-885; 43063-979; 50090-6387; 51224-001; 53002-0411; 60429-914; 62332-426; 63187-185; 63629-2443; 63629-2473; 67296-1833; 68071-2562; 68788-7607; 70518-2491; 71205-605; 72189-192; 31722-956; 42806-714; 50090-5409; 50090-6294; 53002-5890; 59762-1122; 62135-441; 63629-2475; 63629-2476; 68071-5223; 68788-8127; 70518-2873; 70518-3542; 71205-699; 71335-1927; 71335-2021; 72865-117; 0904-6564; 42192-618; 43063-980; 51224-010; 61919-400; 63187-016; 67296-1751; 69452-143; 71205-886; 71335-0725; 71335-1880; 72865-119; 66499-0068; 81066-0003; 31722-958; 50090-3228; 50090-6228; 51655-762; 65841-843; 67296-1450; 67296-1576; 71205-853; 71335-0031; 71335-0688; 71335-1968; 71610-692; 72189-194; 82982-031; 50090-5986; 53002-5892; 60429-927; 60760-700; 63629-9189; 64380-712; 67296-1290; 67296-1464; 67296-1782; 68071-5083; 68382-247; 68788-7569; 68788-8329; 68788-8336; 71205-632; 71205-673; 71205-972; 0615-8403; 11014-0044; 22568-1005; 65655-0011; 42192-617; 42708-082
UNII 5P4DHS6ENR
Synonyms benzonatate | Tessalon
Chemical Information
Molecular Formula C30H53NO11
CAS Registry Number 104-31-4
SMILES CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hypoaesthesia23.03.03.081; 17.02.06.023--Not Available
Hypokalaemia14.05.03.0020.000031%
Hypomagnesaemia14.04.02.0010.000031%
Hypotension24.06.03.0020.000094%
Hypothermia08.05.01.003; 12.05.03.0010.000031%
Laryngospasm22.04.02.002--
Metabolic acidosis14.01.01.0030.000156%Not Available
Nasal congestion22.04.04.001--
Nausea07.01.07.001--
Pneumothorax22.05.02.0030.000031%
Pruritus23.03.12.001--
Rash23.03.13.001--Not Available
Respiratory acidosis22.02.02.004; 14.01.04.0020.000063%Not Available
Respiratory arrest22.02.01.0090.000141%Not Available
Sedation17.02.04.005--Not Available
Seizure17.12.03.0010.000250%
Sensory loss17.02.07.007--Not Available
Shock24.06.02.002--Not Available
Somnolence17.02.04.006; 19.02.05.0030.000031%
Tachycardia02.03.02.0070.000031%Not Available
Torsade de pointes02.03.04.0050.000141%Not Available
Tremor17.01.06.002--
Unresponsive to stimuli17.02.05.0310.000109%Not Available
Ventricular fibrillation02.03.04.0080.000172%
Ventricular tachycardia02.03.04.0100.000031%
Vomiting07.01.07.0030.000084%
Bradyarrhythmia02.03.02.0150.000031%Not Available
Clonic convulsion17.12.03.008--Not Available
Brain injury19.07.03.007; 17.11.01.0030.000078%Not Available
Gastrointestinal tract irritation07.08.03.008--Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene